Cansino Biologics Inc (688185) — Cash Flow Quality Index

Latest as of September 2025: 1.09x

Cansino Biologics Inc (688185) has a Cash Flow Quality Index of 1.09x as of September 2025. Operating cash flow of CN¥30.53 Million exceeds net income of CN¥27.93 Million, indicating high earnings quality where cash backs reported profits. Explore Cansino Biologics Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

1.09x
Operating CF / Net Income

Operating Cash Flow

CN¥30.53 Million
CNY

Net Income

CN¥27.93 Million
CNY

Data as of

Sep 2025
Most recent filing

Cansino Biologics Inc Cash Flow Quality Index (2021–2025)

Historical Cash Flow Quality Index for Cansino Biologics Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Cansino Biologics Inc cash conversion from operations.

Annual Cash Flow Quality Index for Cansino Biologics Inc (2021–2025)

Year-by-year earnings quality comparison for Cansino Biologics Inc.

Year Quality Index Operating CF (CNY) Net Income YoY Change
2025 2.79x CN¥77.86 Million CN¥27.87 Million ▲ +164.4%
2021 1.06x CN¥2.01 Billion CN¥1.91 Billion —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.